RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:awful is the word Sorry to hear man. Most of us are all underwater here too- I invested with the same perspective - good products.
Top line revenue wasn't great - and my patients is thinning as well. But it was a transition quarter with Colin doing a lot of restructuring. Sales team
didn't really kick in until late Q3.
Given the products coming to market and new sales and distribution strategy - I need to see how the whole
package comes together in Q4.
which should be when the whole sector runs into a USA election and potential legalization in USA.
best of luck